Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
McAdoo, Stephen P., Tanna, Anisha, Hrušková, Zdenka, Holm, Lisa, Weiner, Maria, Arulkumaran, Nishkantha, Kang, Amy, Satrapová, Veronika, Levy, Jeremy, Ohlsson, Sophie, Tesar, Vladimir, Segelmark, MårtLanguage:
english
Journal:
Kidney International
DOI:
10.1016/j.kint.2017.03.014
Date:
May, 2017
File:
PDF, 858 KB
english, 2017